Impaired metabolic activation in Alzheimer's disease: A pet study during continuous visual recognition

Regional cerebral metabolic rate of glucose (rCMRGl) was studied in 21 patients with probable Alzheimer's disease (AD) and nine age-matched normal controls by positron emission tomography (PET) of 2(18F)-fluoro-deoxy-D-glucose (FDG) at rest and during stimulation with a continuous visual recognition task. While global metabolism at rest was comparable in both groups, rCMRGl in the temporo-parietal junction area, the mid-temporal and the frontal cortex was typically decreased in the AD patients. The continuous visual recognition task adapted to the individual performance capacity increased the global metabolic rate in the controls by 21 +/- 18%, while in the AD patients the metabolic change (5.7 +/- 11.1%) during activation was significantly weaker (P = 0.023). Due to the tasks chosen the activation of rCMRGl in both groups was most prominent in the visual cortex and the temporo-parietal association areas, although the recognition task additionally involved widespread brain structures with varying rCMRGl. A significant correlation was found between rCMRGl in areas usually severely affected by AD pathology, e.g. the temporo-parietal cortex, and GDS scores, and became stronger during metabolic activation. Neither at rest nor during stimulation was there a relationship between the rCMRGl of structures usually less involved in AD, e.g. the sensorimotor cortex, and the severity of dementia as assessed by the global deterioration scale (GDS). From these results it can be concluded that metabolic rate at rest reflects the extent of morphologic damage, while PET studies during activation indicate the brain's reserve capacity to respond to functional tasks. Since metabolism in AD patients during activation is more severely impaired than at rest, PET studies during functional tests could help in the selection of patients with a potential to benefit from therapeutic intervention.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  J. Haxby,et al.  Positron emission tomography in Alzheimer's disease , 1986, Neurology.

[3]  A. Burns Clinical diagnosis of Alzheimer's disease , 1991 .

[4]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[5]  K Wienhard,et al.  Computer Assisted Mapping in Quantitative Analysis of Cerebral Positron Emission Tomograms , 1985, Journal of computer assisted tomography.

[6]  C. L. Grady,et al.  Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type , 1986, Neurology.

[7]  L. DeLisi,et al.  Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. , 1987, Life sciences.

[8]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[9]  A. Alavi,et al.  Positron emission tomographic studies of sensory stimuli, cognitive processes and anxiety. , 1983, Human neurobiology.

[10]  R. Katzman.,et al.  Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.

[11]  B. Reisberg,et al.  Computed Tomography and Positron Emission Transaxial Tomography Evaluations of Normal Aging and Alzheimer's Disease , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  J D Brodie,et al.  Reproducibility of Cerebral Glucose Metabolic Measurements in Resting Human Subjects , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  J M VANDERPLAS,et al.  The association value of random shapes. , 1959, Journal of experimental psychology.

[14]  R. C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[15]  J. Haxby,et al.  Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. , 1986, Archives of neurology.

[16]  D. Loewenstein,et al.  Behavioral Activation and the Variability of Cerebral Glucose Metabolic Measurements , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  E. S. Gollin,et al.  Developmental Studies of Visual Recognition of Incomplete Objects , 1960 .

[18]  E. Renzi,et al.  The token test: A sensitive test to detect receptive disturbances in aphasics. , 1962, Brain : a journal of neurology.

[19]  J. Botwinick Disinclination to venture response versus cautiousness in responding: age differences. , 1969, The Journal of genetic psychology.

[20]  William Hodos,et al.  Nonparametric index of response bias for use in detection and recognition experiments. , 1970 .

[21]  Stephen W. Scheff,et al.  Quantitative assessment of cortical synaptic density in Alzheimer's disease , 1990, Neurobiology of Aging.

[22]  D. Loewenstein,et al.  Cerebral metabolic effects of a verbal fluency test: a PET scan study. , 1988, Journal of clinical and experimental neuropsychology.

[23]  R J Zatorre,et al.  Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[25]  Y Yonekura,et al.  Use of 2-Deoxy-D[1-11C]Glucose for the Determination of Local Cerebral Glucose Metabolism in Humans: Variation within and between Subjects , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  J. Halter,et al.  Impaired sympathetic nervous system response to cognitive effort in early Alzheimer's disease. , 1989, Journal of gerontology.

[27]  C. Nemeroff,et al.  Neurotransmitters and neuropeptides in Alzheimer's disease. , 1991, The Psychiatric clinics of North America.

[28]  J. Mazziotta,et al.  Study of Cerebral Function with Positron Computed Tomography , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  W. Heiss,et al.  Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects. , 1989, The Keio journal of medicine.

[30]  D. M. Green,et al.  Signal detection theory and psychophysics , 1966 .

[31]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[32]  Ruben C. Gur,et al.  A cognitive-motor network demonstrated by positron emission tomography , 1983, Neuropsychologia.

[33]  B. Reisberg,et al.  Abnormal Temporal Lobe Response in Alzheimer's Disease during Cognitive Processing as Measured by 11C-2-Deoxy-D-Glucose and PET , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  A. Alavi,et al.  The Effect of Anxiety on Cortical Cerebral Blood Flow and Metabolism , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  J. G. Snodgrass,et al.  Pragmatics of measuring recognition memory: applications to dementia and amnesia. , 1988, Journal of experimental psychology. General.

[36]  H. Braak,et al.  Demenz mit argyrophilen Körnchen — Morphologie einer bisher unbekannten zur Demenz führenden Erkrankung , 1988 .

[37]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[38]  W. Heiss,et al.  Positron Emission Tomography and Neuropsychological Function , 1989 .

[39]  P. Coleman,et al.  Dendritic growth in the aged human brain and failure of growth in senile dementia. , 1979, Science.

[40]  A. Alavi,et al.  The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane , 1979, Circulation research.

[41]  R H Huesman,et al.  Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.